Core Viewpoint - The report outlines the equity change of Anhui Hongyu Wuzhou Medical Devices Co., Ltd. (Wuzhou Medical), indicating a reduction in shareholding by the information disclosing party, Taihu Honghui Medical Management Partnership, and its concerted actions [1][2]. Group 1: Equity Change Details - The equity change is based on the information disclosing party's financial planning, executed through a centralized bidding method to reduce company shares [5]. - As of the report's signing date, the information disclosing party and its concerted actions hold a combined shareholding of 35.1612% in the company, calculated based on a total share capital of 68,000,000 shares [10]. - The information disclosing party has no plans to increase its shareholding in the next 12 months and may continue to reduce its shares through centralized bidding and block trading [6]. Group 2: Legal Compliance and Responsibilities - The report complies with the relevant laws and regulations, ensuring that the information disclosing party has the necessary authorization and approval for the equity change [1][2]. - The information disclosing party commits that the report contains no false records, misleading statements, or significant omissions, and assumes legal responsibility for its accuracy and completeness [2][15]. Group 3: Impact on the Company - The equity change will not result in a change of control for the company, nor will it affect its main business operations, financial independence, or governance structure [11].
安徽宏宇五洲医疗器械股份有限公司简式权益变动报告书